Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Deferred Taxes: 2021-2024

Historic Deferred Taxes for Ironwood Pharmaceuticals (IRWD) over the last 4 years, with Dec 2024 value amounting to $68.1 million.

  • Ironwood Pharmaceuticals' Deferred Taxes rose 261.57% to $27.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $83.7 million, marking a year-over-year increase of 43.47%. This contributed to the annual value of $68.1 million for FY2024, which is 6.26% down from last year.
  • Ironwood Pharmaceuticals' Deferred Taxes amounted to $68.1 million in FY2024, which was down 6.26% from $72.6 million recorded in FY2023.
  • Over the past 5 years, Ironwood Pharmaceuticals' Deferred Taxes peaked at $72.6 million during FY2023, and registered a low of -$333.3 million during FY2021.
  • Moreover, its 3-year median value for Deferred Taxes was $68.1 million (2024), whereas its average is $68.8 million.
  • In the last 5 years, Ironwood Pharmaceuticals' Deferred Taxes surged by 119.72% in 2022 and then decreased by 6.26% in 2024.
  • Yearly analysis of 4 years shows Ironwood Pharmaceuticals' Deferred Taxes stood at -$333.3 million in 2021, then skyrocketed by 119.72% to $65.7 million in 2022, then rose by 10.49% to $72.6 million in 2023, then fell by 6.26% to $68.1 million in 2024.